Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 7/2009

01-07-2009 | Gastrointestinal Oncology

Progress and Limitations of Surgery in Improving Outcomes of Esophagogastric Junction Cancer

Authors: George E. Chalkiadakis, MD, Dimosthenis Ziogas, MD

Published in: Annals of Surgical Oncology | Issue 7/2009

Login to get access

Excerpt

TO THE EDITORS: …
Literature
1.
Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol. 2005;90(3):139–46; discussion 146.PubMedCrossRef
2.
Kappas AM, Roukos DH. Quality of surgery determinant for the outcome of patient with gastric cancer. Ann Surg Oncol. 2002 Nov;9(9):828–30.PubMedCrossRef
3.
Roukos DH, Paraschou P, Lorenz M. Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol. 2000;7(10):719–26.PubMedCrossRef
4.
Liakakos T, Roukos DH. More controversy than ever – challenges and promises towards personalized treatment of gastric cancer. Ann Surg Oncol. 2008;15(4):956–60.PubMedCrossRef
5.
Carboni F, Lorusso R, Santoro R, Lepiane P, Mancini P, Sperduti I, et al. Adenocarcinoma of the Esophagogastric Junction: The Role of Abdominal-Transhiatal Resection. Ann Surg Oncol. 2009;16(2):304–10.PubMedCrossRef
6.
Roukos DH, Lorenz M, Karakostas K, Paraschou P, Batsis C, Kappas AM. Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study. Br J Cancer. 2001;84(12):1602–9.PubMedCrossRef
7.
Roukos DH. Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery. Expert Rev Mol Diagn. 2008;8(5):587–97.PubMedCrossRef
8.
Roukos DH, Lykoudis E, Liakakos T. Genomics and challenges toward personalized breast cancer local control. J Clin Oncol. 2008;26(26):4360–1.PubMedCrossRef
9.
Sasako M, Sano T, Yamamoto S, et al. for Japan Clinical Oncology Group D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med. 2008;359(5):453–62.PubMedCrossRef
10.
Roukos DH. 21-gene assay: Challenges and promises in translating personal genomics and whole genome scans into personalized treatment of breast cancer. J Clin Oncol. (in press).
11.
Roukos DH. Breast-cancer stromal cells with TP53 mutations. N Engl J Med. 2008;358(15):1636.PubMed
12.
Ziogas D, Baltogiannis G, Fatouros M, et al. Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg. 2008;247(4):714–5.PubMedCrossRef
13.
Roukos DH. Assessing both genetic variation (SNPs/CNVs) and interactions with the environment may lead to personalized gastric cancer prevention. Expert Rev Mol Diagn. 2009;9(1):1–6.PubMedCrossRef
14.
15.
Fatouros M, Baltoyiannis G, Roukos DH. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol. 2008;15(1):21–33.PubMedCrossRef
16.
17.
Roukos DH. Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer. Ann Surg Oncol. 2009;16(4):795–8.PubMedCrossRef
18.
Roukos DH. Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine. Ann Surg Oncol.2009;16(3):772–3.PubMedCrossRef
Metadata
Title
Progress and Limitations of Surgery in Improving Outcomes of Esophagogastric Junction Cancer
Authors
George E. Chalkiadakis, MD
Dimosthenis Ziogas, MD
Publication date
01-07-2009
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 7/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0461-1

Other articles of this Issue 7/2009

Annals of Surgical Oncology 7/2009 Go to the issue

Gynecologic Oncology

Pathological Diagnosis and Cytoreduction of Cardiophrenic Lymph Node and Pleural Metastasis in Ovarian Cancer Patients Using Video-Assisted Thoracic Surgery

Endocrine Tumors

Expression of the Transcription Factor Snail and Its Target Gene Twist Are Associated with Malignancy in Pheochromocytomas

Translational Research and Biomarkers

Preoperative u-PAR Gene Expression in Bone Marrow Indicates the Potential Power of Recurrence in Breast Cancer Cases

Consensus Report: Resectable and Borderline Resectable Pancreas Cancer

Surgical Treatment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement by Evans et al.

Thoracic Oncology

Centralization of Esophageal Cancer Surgery: The Right Thing to Do Is Seldom Easy

Gastrointestinal Oncology

Adjustment of N Stages of Gastric Cancer by the Ratio Between the Metastatic and Examined Lymph Nodes